What is the Org number of Atos Medical Holding AB?

Atos Medical Holding AB is registered with Bolagsverket / SCB under Org 5590641527.

What is the revenue of Atos Medical Holding AB?

Atos Medical Holding AB reported revenue of SEK 7,5M in 2025.

Atos Medical Holding AB employs 1 people as of the latest annual report.

Egil Molsted Madsen is External Signatory of Atos Medical Holding AB, in role since 2020.

Henrik Deneke chairs the board of Atos Medical Holding AB, in role since 2022.

ABDissolved

Org 5590641527Activities of head offices · NACE 7010Est. 20161 employees

Actively employed in the business

Name	Role	Member since
Current (2)
CV Caroline Vagner Rosenstand Chief Executive Officer	Chief Executive Officer	2022
PA Pia Agneta Anell Chief Auditor	Chief Auditor	2024
Former (6)
EM Egil Molsted Madsen External Signatory	External Signatory	2020 – 2022
SM Sven Mattias Lamme Chief Auditor	Chief Auditor	2022 – 2024
JP John Philip Hansveden External Signatory	External Signatory	2022 – 2024
LF Lars Frederiksen Chief Executive Officer	Chief Executive Officer	2021 – 2022
BM Britt Meelby Jensen Chief Executive Officer	Chief Executive Officer	2022 – 2022
MS Maria Sofia Ekelund Chief Auditor	Chief Auditor	2020 – 2022

Non-executive oversight

Name	Role	Member since
Current (4)
AM Anton Malling Mikkelsen	Board of Directors	2024
LG Lars Göran Jönsson	Board of Directors	2022
JB Johan Bertil Månsson	Board of Directors	2022
HD Henrik Deneke	Chairman	2022
Former (7)
CM Cecilia Margaretha Daun Wennborg	Board of Directors	2020 – 2022
AG Andreas Georg Kumeth	Board of Directors	2020 – 2022
EA Emil Anders Billbäck	Board of Directors	2022 – 2022
LN Lars Nilaus Neuteboom Nielsen	Board of Directors	2022 – 2024
RH Ragnar Hellenius	Board of Directors	2020 – 2022
SM Sofia Margareta Hasselberg	Board of Directors	2022 – 2022
HV Hea Vinskov	Board of Directors	2022 – 2024

As of last annual report

Shareholder	Type	Ownership	Votes	Since
COLOPLAST A/S	Company	100%	100%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.